| Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab (NCT06249048) | Strand Therapeutics Inc. | 2024-05-03 |
| A Clinical Trial to Evaluate the Food Effect of CKD-378 (NCT06386328) | Chong Kun Dang Pharmaceutical | 2024-05-03 |
| A Phase 1, Open-label Study Evaluating the Pharmacokinetics and Drug-drug Interaction of VX-993 in Healthy Adults (NCT06392659) | Vertex Pharmaceuticals Incorporated | 2024-05-02 |
| Impact of Selenium on Methotrexate Induced Spermatotoxicity; A Comparative Study (NCT06951282) | Ain Shams University | 2024-05-02 |
| Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML) (NCT06326697) | Hikma Pharmaceuticals LLC | 2024-05-02 |
| A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers (NCT06346184) | Hanmi Pharmaceutical Company Limited | 2024-05-02 |
| A First in Human Trial Evaluating THB335 in Healthy Participants (NCT06425861) | Third Harmonic Bio, Inc. | 2024-05-02 |
| Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone (NCT06388616) | AstraZeneca | 2024-05-02 |
| Multi-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia Patients (NCT06252584) | University Hospital Tuebingen | 2024-05-02 |
| First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM) (NCT05921929) | ReST Therapeutics | 2024-05-02 |
| Multimodal Imaging in Rectal Cancer & Pancreatic Cancer (NCT06395337) | Radboud University Medical Center | 2024-05-02 |
| Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC (NCT06346808) | Sichuan University | 2024-05-01 |
| Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study. (NCT06230146) | Assiut University | 2024-05-01 |
| The Assessment of Curcuma Longa Potentials for Soft and Hard Tissue Healing in Fresh (NCT05816707) | Rania Farouk Mohamed Abdulmaguid | 2024-05-01 |
| Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma (NCT06552559) | Samsung Medical Center | 2024-05-01 |
| Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease (NCT06866158) | PT. JES Kasih Nusantara Sejahterah | 2024-05-01 |
| I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers (NCT05986071) | Institut Paoli-Calmettes | 2024-05-01 |
| A Combination of an Inhaled Budesonide and Ipratropium in Patients at Risk of Developing ARDS (NCT06657079) | Damanhour University | 2024-05-01 |
| Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis (NCT06400056) | Assiut University | 2024-05-01 |
| Comparison of HR011408 and NovoRapid® in Subjects With Diabetics (NCT06375031) | Jiangsu HengRui Medicine Co., Ltd. | 2024-05-01 |
| Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink (NCT05882214) | Zhejiang Chinese Medical University | 2024-05-01 |
| A Study to Evaluate the Mass Balance of [14C] SY-5007 in Healthy Adult Male Subjects in China (NCT06352190) | Shouyao Holdings (Beijing) Co. LTD | 2024-05-01 |
| Safety of ENC-201-CED ENCRT (NCT06408311) | Encellin | 2024-05-01 |
| Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy (NCT06304896) | Arab Contractors Medical Centre | 2024-05-01 |
| A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine STR-V003 in Healthy Adults (NCT06344975) | Starna Therapeutics | 2024-05-01 |
| ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC (NCT06351332) | Filipa Lynce, MD | 2024-05-01 |
| Evaluation of The Efficacy And Safety of PD-1 + IL-2 Combined With Capox Treatment After Loop Colostomy Surgery in Left-sided Colorectal Cancer Patients Complicating Acute Obstruction (NCT06394791) | The First Affiliated Hospital with Nanjing Medical University | 2024-05-01 |
| NM32-2668 in Adult Patients With Selected Advanced Solid Tumors (NCT06299163) | Numab Therapeutics AG | 2024-05-01 |
| SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer (NCT06373133) | West China Hospital | 2024-05-01 |
| Safety and Efficacy of Stem Cells for Diabetic Foot Ulcer (NCT06231771) | Supergenics Life Science Sdn. Bhd. | 2024-05-01 |
| CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study) (NCT06002659) | Uppsala University | 2024-05-01 |
| Self-Management Program for AIS D SCI (NCT05800717) | VA Office of Research and Development | 2024-05-01 |
| A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis (NCT06055374) | Brexogen Inc. | 2024-05-01 |
| Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDer (NCT06385548) | Vall d'Hebron Institute of Oncology | 2024-05-01 |
| Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department (NCT06085937) | Lindsay Maguire, MD | 2024-05-01 |
| Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer (NCT06395844) | Anhui Provincial Cancer Hospital | 2024-05-01 |
| Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors (NCT06384352) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2024-05-01 |
| Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC) (NCT06337162) | Abramson Cancer Center at Penn Medicine | 2024-05-01 |
| Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder (NCT06279286) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2024-05-01 |
| Oxytocin Administration to Therapists and Its Effects on Patient-perceived Attunement and Responsiveness (NCT06332066) | Shalvata Mental Health Center | 2024-05-01 |
| A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer (NCT06163391) | SOTIO Biotech AG | 2024-05-01 |
| Efficacy of Jelly Fig (Ficus Awkeotsang Makino) Extract for Atopic Dermatitis (NCT07113366) | Kaohsiung Veterans General Hospital. | 2024-05-01 |
| Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo Transfer (NCT06379659) | Isfahan University of Medical Sciences | 2024-05-01 |
| PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study) (NCT06345599) | Second Affiliated Hospital of Soochow University | 2024-05-01 |
| Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023) (NCT06502834) | Max Nieuwdorp | 2024-05-01 |
| A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients (NCT06237777) | Wang Min | 2024-05-01 |
| The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD. (NCT03752918) | Yale University | 2024-05-01 |
| Covid-19 and Influenza Oral Vaccine Study (NCT06355232) | Vaxine Pty Ltd | 2024-05-01 |
| SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma (NCT06384482) | Shanghai Simnova Biotechnology Co.,Ltd. | 2024-04-30 |
| A Study in Healthy People to See How Zongertinib is Taken up Into the Blood When Given as Tablets Made by Two Different Manufacturers (NCT06360081) | Boehringer Ingelheim | 2024-04-30 |
| Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator (NCT06233240) | Bio-innova Co., Ltd | 2024-04-30 |
| A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function (NCT06340347) | Pfizer | 2024-04-30 |
| Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects (NCT06171048) | Keymed Biosciences Co.Ltd | 2024-04-30 |
| A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity (NCT06352424) | Boehringer Ingelheim | 2024-04-30 |
| Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma (NCT06242249) | Shahid Beheshti University of Medical Sciences | 2024-04-30 |
| Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia (NCT06367673) | Zhejiang University | 2024-04-30 |
| To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid Tumors (NCT06592417) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2024-04-30 |
| A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants (NCT06344728) | Insmed Incorporated | 2024-04-30 |
| Newly Emerging Immunotherapy for Pancreatic Cancer Treatment (NCT06370754) | Fudan University | 2024-04-30 |
| A Study to Learn How Different Forms of the Study Medicine Called PF-06954522 Are Taken up Into the Blood in Healthy Adults (NCT06393517) | Pfizer | 2024-04-30 |
| A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma (NCT06464185) | Institute of Hematology & Blood Diseases Hospital, China | 2024-04-30 |
| Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells (NCT06186401) | Hideho Okada, MD, PhD | 2024-04-30 |
| First-into-human Study of NS-136 in Healthy Subjects (NCT06345703) | NeuShen Therapeutics | 2024-04-30 |
| A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease (NCT06164730) | Verve Therapeutics, Inc. | 2024-04-30 |
| Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage (NCT05617833) | Johns Hopkins University | 2024-04-30 |
| Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours. (NCT06304818) | Sinocelltech Ltd. | 2024-04-30 |
| S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP (NCT06188702) | Servier Bio-Innovation LLC | 2024-04-29 |
| A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants (NCT06640920) | Uniquity One (UNI) | 2024-04-29 |
| A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia (NCT06387420) | Akeso | 2024-04-29 |
| A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation (NCT06385925) | Tyligand Pharmaceuticals (Suzhou) Limited | 2024-04-29 |
| A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment (NCT06352528) | Bristol-Myers Squibb | 2024-04-29 |
| Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain (NCT05909709) | Alimorad Farshchian | 2024-04-29 |
| A Study to Assess the Pharmacokinetics and Safety of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-Generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer (NCT06297668) | AstraZeneca | 2024-04-29 |
| A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma (NCT06234605) | HiberCell, Inc. | 2024-04-29 |
| A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements (NCT06258265) | Takeda | 2024-04-29 |
| Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) (NCT06294236) | Sana Biotechnology | 2024-04-29 |
| A Study to Evaluate the Tolerability, Safety and Efficacy of VGM-R02b (NCT06217861) | Shanghai Vitalgen BioPharma Co., Ltd. | 2024-04-29 |
| Phase I Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Injection of SHR-2173 in Healthy Subjects (NCT06995001) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-04-28 |
| To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage (NCT06376474) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2024-04-28 |
| Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL (NCT06080191) | Bambino Gesù Hospital and Research Institute | 2024-04-28 |
| Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder (NCT06376331) | The Second Hospital of Nanjing Medical University | 2024-04-28 |
| Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years (NCT06675032) | Reinovax Biologics Co., LTD | 2024-04-27 |
| Metabolic Changes in Healthy Subjects with Acute Binge Drink (NCT06298318) | Zhejiang Chinese Medical University | 2024-04-27 |
| Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects (NCT06354556) | Shandong Suncadia Medicine Co., Ltd. | 2024-04-26 |
| Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy (NCT05398302) | Jonsson Comprehensive Cancer Center | 2024-04-26 |
| Study of REM-422 in Patients With AML or Higher Risk MDS (NCT06297941) | Remix Therapeutics | 2024-04-26 |
| ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors (NCT06332170) | Hansoh BioMedical R&D Company | 2024-04-26 |
| Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma (NCT06384248) | Letolab | 2024-04-26 |
| Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma (NCT06364787) | Beijing 302 Hospital | 2024-04-26 |
| A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC (NCT06383052) | Norroy Bioscience Co., LTD | 2024-04-26 |
| Nebulized Fentanyl in Healthy Volunteers (NCT06281951) | University Hospital, Rouen | 2024-04-26 |
| Phase II Clinical Study of LTC004 in Patients With mCRC (NCT06384235) | Letolab | 2024-04-25 |
| Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer (NCT06431685) | Sichuan University | 2024-04-25 |
| A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors (NCT06403735) | Qilu Pharmaceutical Co., Ltd. | 2024-04-25 |
| Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN) (NCT06405542) | University Health Network, Toronto | 2024-04-25 |
| Evaluation of Effect of Platelet-Rich Fibrin on Orthodontic Tooth Movement: a Split Mouth Randomised Controlled Trial (NCT06634017) | Dow University of Health Sciences | 2024-04-25 |
| Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus (NCT06498284) | Hua Medicine Limited | 2024-04-25 |
| A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight (NCT06352892) | Amgen | 2024-04-25 |
| ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells (NCT06090864) | UNC Lineberger Comprehensive Cancer Center | 2024-04-25 |
| Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma (NCT06445517) | InSilico Medicine Hong Kong Limited | 2024-04-25 |